CLINICAL_TRIALS
trial_result
· 2011-03-02
Clinical Trial Update: Rosuvastatin in Visceral Adiposity [Phase 3]
Summary
A Phase 3 trial evaluated rosuvastatin for abdominal obesity/visceral adiposity, with results posted in March 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Göteborg University | Conditions: Abdominal Obesity | Phase 3 | Status: COMPLETED | Results posted: 2011-03-02